Bionovo, Inc. (BNVI) Posts Q1 EPS Loss of $0.04 with $65 Thousand in Revenue
Tweet
Share
E-mailGet Alerts BNVI Hot Sheet
Join SI Premium – FREE
Bionovo, Inc. (NASDAQ: BNVI) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $65 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
